Metropolitan Life Insurance CO Uro Gen Pharma Ltd. Transaction History

Metropolitan Life Insurance CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$10.87 - $15.93 $5,521 - $8,092	508 Added 47.12%	1,586 $23,000
Q2 2023 Aug 10, 2023	BUY	$8.75 - $14.29 $9,432 - $15,404	1,078 New	1,078 $11,000
Q3 2021 Jun 21, 2023	BUY	$14.31 - $18.39 $79,606 - $102,303	5,563 New	5,563 $93.6 Million
Q1 2021 Jun 26, 2023	BUY	$17.99 - $26.96 $109,577 - $164,213	6,091 New	6,091 $119 Million
Q4 2020 Jun 22, 2023	BUY	$17.54 - $25.43 $106,836 - $154,894	6,091 New	6,091 $110 Million
Q3 2020 Jun 26, 2023	BUY	$18.81 - $26.42 $114,571 - $160,924	6,091 New	6,091 $117 Million
Q2 2020 Jun 26, 2023	BUY	$16.5 - $29.7 $100,501 - $180,902	6,091 New	6,091 $159 Million
Q1 2020 Jul 12, 2023	BUY	$13.68 - $34.6 $93,256 - $235,868	6,817 New	6,817 $122 Million
Q4 2019 Jul 12, 2023	BUY	$21.11 - $34.86 $143,906 - $237,640	6,817 New	6,817 $227 Million
Q3 2019 Jul 12, 2023	BUY	$23.83 - $36.44 $172,219 - $263,351	7,227 New	7,227 $172 Million

130

35.9M

22K

93.8K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $242M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.